
Over the last years, advances in the treatment and supportive care of patients with cancer have led to substantial improvement in long-term zzso Nevertheless, bacterial infection continues to contribute significantly to illness and death in patients developing zzso zzso In this severely ill population, the early administration of appropriate empirical zzso therapy for zzso episodes is zzso This therapeutic approach has been shown to decrease morbidity and mortality due to infections caused by gram negative zzso However, in recent years, gram positive pathogens have been recovered at a notably increased rate from zzso patients with zzso Although mortality associated to gram positive zzso is commonly lower than that caused by gram negative zzso an increasing frequency of serious complications of zzso due to zzso group zzso has been observed in some zzso Moreover, the emerging problems of bacterial resistance to various zzso agents is of great zzso zzso we examine major changes in the epidemiology of bacterial infections in zzso patients with cancer and some clinical aspects of infections caused by most frequent zzso 

